Metabolic-associated fatty liver disease is less effective in predicting mortality than non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease: Letter to the editor on "Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study"

代谢相关性脂肪肝在预测死亡率方面不如非酒精性脂肪肝和代谢功能障碍相关性脂肪肝有效：致编辑的信，主题为“经活检证实的代谢功能障碍相关性脂肪肝的预后：CLIONE 研究的亚组分析”。